21
Views
16
CrossRef citations to date
0
Altmetric
REGULAR ARTICLES

Correlates of Severity of Smoking Among Persons with Severe Mental Illness

, MD, MPH, , PhD, , MS, , MD, MPH, , PhD, , MS, , PhD, , PhD, , PharmD, PhD, , MD, , PhD & , MS show all
Pages 101-110 | Received 24 Feb 2006, Accepted 11 May 2006, Published online: 10 Jul 2009

REFERENCES

  • De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76:135–157.
  • De Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson G. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995;152:453–455.
  • Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143:993–997.
  • Shopland DR, Hartman AM, Gibson JT, Mueller MD, Kessler LG, Lynn WR. Cigarette smoking among U.S. adults by state and region: estimates from the current population survey. J Natl Cancer Inst. 1996;88:1748–1758.
  • Tanskanen A, Viinamaki H, Koivumaa-Honkanen HTJ, Juha J. Smoking among psychiatric patients. Eur Psychiatry. 1997;11:179–188.
  • Waxmonsky JA, Thomas MR, Miklowitz DJ, , et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the systematic treatment enhancement program. Gen Hosp Psychiatry. 2005;27:321–328.
  • Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry. 1998;155:1490–1501.
  • Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis. 1995;183:559–565.
  • Lyon ER. A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv. 1999;50:1346–1350.
  • Esterberg ML, Compton MT. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med. 2005;61:293–303.
  • Forchuk C, Norman R, Malla A, , et al. Schizophrenia and the motivation for smoking. Perspect Psychiatr Care. 2002;38:41–49.
  • Patkar AA, Gopalakrishnan R, Lundy A, Leone FT, Certa KM, Weinstein SP. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis. 2002;190:604–610.
  • Lucksted A, Dixon LB, Sembly JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatr Serv. 2000;51:1544–1548.
  • Leonard S, Adams C, Breese CR, , et al. Nicotinic receptor function in schizophrenia. Schizophr Bull. 1996;22:431–445.
  • McEvoy JP, Allen TB. The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Curr Drug Targets CNS Neurol Disord. 2002;1:433–442.
  • Taiminen TJ, Salokangas RK, Saarijarvi S, , et al. Smoking and cognitive deficits in schizophrenia: a pilot study. Addict Behav. 1998;23:263–266.
  • Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004;29:1067–1083.
  • Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrrenic patients in Nithsdale, Scotland. Am J Psychiatry. 1999;156:1751–1757.
  • Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA. 2005;294:1505–1510.
  • Himelhoch S, Moates A, Lehman A, Dixon L. Racial differences in rates and patterns of smoking exist among individuals with serious mental illness. J Assoc Acad Minor Phys. 2005;16:43–50.
  • Stellman SD, Chen Y, Muscat JE, , et al. Lung cancer risk in white and black Americans. Ann Epidemiol. 2003;13:294–302.
  • Hahn LP, Folsom AR, Sprafka JM, Norsted SW. Cigarette smoking and cessation behaviors among urban blacks and whites. Public Health Rep. 1990;105:290–295.
  • Wagenknecht LE, Cutter GR, Haley NJ, , et al. Racial differences in serum cotinine levels among smokers in the coronary artery risk development in (young) adults study. Am J Public Health. 1990;80:1053–1056.
  • Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 1994;45:204–206.
  • Aguilar MC, Gurpegui M, Diaz F, De Leon J. Nicotine dependence and symptoms of schizophrenia. Br J Psychiatry. 2005;186:215–221.
  • de Leon J, Diaz FJ, Josiassen RC, Cooper TB, Simpson GM. Does clozapine decrease smoking? Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:757–762.
  • DHHS. U.S. Department of Health and Human Services, National Center for Health Statistics: The third national health and nutrition examination survey 1988–94 (NHANES III). Hyattsville, Md.: Center for Disease Control and Prevention; 1998.
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction. 1991;86:1119–1127.
  • DiClemente CC. Addiction and Change: How Addictions Develop and Addicted People Recover. New York: Guilford Press; 2003.
  • DiClemente CC, Schlundt D, Gemell L. Readiness and stages of change in addiction treatment. Am J Addict. 2004;13:103–119.
  • Bedfont Scientific U. EC50 Microl III Smokerlyzer Breath Carbon Monoxide Monitor. Medford, New Jersey, USA.
  • Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J. 1980;281:484–485.
  • DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59:295–304.
  • Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce J. Distribution of smokers by stage in three representative samples. Prev Med. 1995;24:401–411.
  • Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905–1907.
  • Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;10:1121–1123.
  • Hays RD, Merz JF, Nicholas R. Response burden, reliability, and validity of the CAGE, short MAST, and AUDIT alcohol screening measures. Behav Res Methods Instrum Comput. 1995;27:277–280.
  • Perkins D, Stroup TS, Lieberman JA. Psychotic disorders measures. In: Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association Press; 2000:485–513.
  • Cohen S, Kamarack T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:31–67.
  • Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Scacapan S, Oskamp S, eds. The Social Psychology of Health. Newbury Park, Calif.: Sage; 1988:31–67.
  • Lehman AF. A quality of life interview for the chronically mentally ill. Evaluation and Program Planning. 1988;11:51–62.
  • Maurice E, Trosclain A, Merritt R, Caraballo R, Malarcher A, Husten C, Pechacek T. “Cigarette Smoking Amoung Adults–United States,” 2004. MMWR Weekly. 2005;54:1121–1124.
  • Murray RP, Connett JE, Buist AS, Gerald LB, Eichenhorn MS. Experience of black participants in the lung health study smoking cessation intervention program. Nicotine Tob Res. 2001;3:375–382.
  • Perez-Stable EJ, Herrera B, Jacob PI, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280:152–156.
  • Zevin S, Benowitz NL. Drug interactions with tobacco smoking. an update. Clin Pharmacokinet. 1999;36:425–438.
  • Caraballo RS, Giovino GA, Pechacek TF, , et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: third national health and nutrition examination survey 1988–1991. JAMA. 1998;280:135–139.
  • Avila MT, Sherr JD, Hong E, Myers CS, Thaker GK. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia. Neuropsychopharmacology. 2003;28:2184–2191.
  • Depatie L, O'Driscoll GA, Holahan AL, , et al. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology. 2002;27:1056–1070.
  • Myers CS, Robles O, Kakoyannis AN, , et al. Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl). 2004;174:334–340.
  • Olincy A, Johnson LL, Ross RG. Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Res. 2003;117:223–236.
  • Haiman CA, Stram DO, Wilkens LR, , et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354:333–342.
  • Hatsukami DK, Kotlyar M, Allen S, , et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128:2528–2537.
  • Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen centre for prospective population studies. Am J Epidemiol. 2002;156:994–1001.
  • Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820.
  • Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 2005;41:244–260.
  • Porter JA, von Fraunhofer JA. Success or failure of dental implants? A literature review with treatment considerations. Gen Dent. 2005;53:423–432.
  • Andrews JA, Severson HH, Lichtenstein E, Gordon JS. Relationship between tobacco use and self-reported oral hygiene habits. J Am Dent Assoc. 1998;129:313–320.
  • Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003;41:560–570.
  • Ziedonis D, Williams JM, Smelson DS. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003;326:223–230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.